ArticleDiabetes, obesity & metabolism2020

Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trials.

Vanita R Aroda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.